RHOA and cancer: Our results, using stable HeLa cell lines expressing either a constitutively active RhoA (RhoA-V14) or a dominant negative version of this protein (RhoA-N19), suggest that RhoA GTPase activity also regulates cancer cell sensitivity to γ-radiation, by affecting basic DNA repair mechanisms.